These findings define a lysosomal pathway linking granulin deficiency to TMEM106B C-terminal fragment accumulation and explain how protective <i>TMEM106B</i> alleles can confer resistance to FTD, even for <i>GRN</i> mutation carriers. The gene discussed is GRN; the disease is frontotemporal dementia.